Autosomal dominant proximal renal tubular acidosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:314889N25.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autosomal dominant proximal renal tubular acidosis (proximal RTA type 2) is a rare inherited kidney condition that affects how the kidneys handle bicarbonate, an important substance that helps keep your blood at the right acid-base balance. In a healthy kidney, the proximal tubule (an early part of the kidney's filtering system) reabsorbs most of the bicarbonate from the urine back into the blood. In this disease, the proximal tubule cannot properly reclaim bicarbonate, so too much of it is lost in the urine. This leads to a buildup of acid in the blood, a condition called metabolic acidosis. Because this form is autosomal dominant, only one copy of the changed gene (inherited from one parent) is enough to cause the disease. Key symptoms can include poor growth in children, fatigue, muscle weakness, bone softening, and sometimes kidney stones. Some patients may also have low potassium levels, which can cause additional muscle problems or heart rhythm concerns. Treatment focuses on correcting the acid-base imbalance by giving oral bicarbonate or citrate supplements. While there is no cure that fixes the underlying kidney defect, ongoing supplementation can help maintain normal blood pH, support growth in children, and prevent complications like bone disease. Regular monitoring by a kidney specialist is important to adjust treatment and watch for complications over time.

Also known as:

Key symptoms:

Excessive acid in the blood (metabolic acidosis)Poor growth or failure to thrive in childrenFatigue and low energyMuscle weaknessBone softening or rickets in childrenBone painLow potassium levelsIncreased urinationExcessive thirstNausea or vomitingLoss of appetiteKidney stones in some casesDifficulty gaining weight

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autosomal dominant proximal renal tubular acidosis.

View clinical trials →

No actively recruiting trials found for Autosomal dominant proximal renal tubular acidosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autosomal dominant proximal renal tubular acidosis community →

No specialists are currently listed for Autosomal dominant proximal renal tubular acidosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autosomal dominant proximal renal tubular acidosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autosomal dominant proximal renal tubular acidosisForum →

No community posts yet. Be the first to share your experience with Autosomal dominant proximal renal tubular acidosis.

Start the conversation →

Latest news about Autosomal dominant proximal renal tubular acidosis

No recent news articles for Autosomal dominant proximal renal tubular acidosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is my current bicarbonate level and how far is it from normal?,How much bicarbonate supplement do I need to take each day, and how should I space the doses?,Do I also need potassium or vitamin D supplements?,What signs should I watch for that would mean I need emergency care?,Should my family members be tested for this condition?,How often do I need blood and urine tests to monitor my condition?,Are there any foods or medications I should avoid?

Common questions about Autosomal dominant proximal renal tubular acidosis

What is Autosomal dominant proximal renal tubular acidosis?

Autosomal dominant proximal renal tubular acidosis (proximal RTA type 2) is a rare inherited kidney condition that affects how the kidneys handle bicarbonate, an important substance that helps keep your blood at the right acid-base balance. In a healthy kidney, the proximal tubule (an early part of the kidney's filtering system) reabsorbs most of the bicarbonate from the urine back into the blood. In this disease, the proximal tubule cannot properly reclaim bicarbonate, so too much of it is lost in the urine. This leads to a buildup of acid in the blood, a condition called metabolic acidosis.

How is Autosomal dominant proximal renal tubular acidosis inherited?

Autosomal dominant proximal renal tubular acidosis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.